---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-034432"
form_type: "8-K"
ticker: "DMLP"
cik: "0001172358"
company_name: "DORCHESTER MINERALS, L.P."
filed_at: "2025-11-12T23:59:59+00:00"
generated_at: "2026-05-16T20:54:27.392478+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Dorchester Minerals manager Bill Russell dies; Nasdaq audit committee now non-compliant, cure period granted

## Summary
- C.W. 'Bill' Russell, manager and Advisory Committee member since 2004, passed away on October 30, 2025.
- Advisory Committee reduced to two members, breaching Nasdaq audit committee minimum of three.
- Nasdaq granted cure period until earlier of next annual meeting or October 30, 2026; if meeting before April 28, 2026, compliance due by then.
- Partnership and General Partner intend to appoint a qualified replacement before cure period expires.

## SEC filing metadata
- accession: 0001437749-25-034432
- form_type: 8-K
- ticker: DMLP
- cik: 0001172358
- company_name: DORCHESTER MINERALS, L.P.
- filed_at: 2025-11-12T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1172358/000143774925034432/0001437749-25-034432-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1172358/000143774925034432/dmlp20251112_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-034432
- JSON: https://secwatch.observer/filing/0001437749-25-034432.json
- Plain text: https://secwatch.observer/filing/0001437749-25-034432.txt

## Source-grounded claims
- claim_id: 639c41aadf45070450f1e51e91d0f26dcc8ea35c
  claim: DORCHESTER MINERALS, L.P. received a nasdaq deficiency notice notice regarding audit committee (rules 5615(a)(4)(C), 5605(c)(2)(A), 5605, 5605(c)(4)).
  evidence_excerpt: November 10, 2025, the Partnership received a letter from Nasdaq acknowledging the Partnership’s non-compliance with Nasdaq’s audit committee requirements as set forth in Nasdaq’s Listing Rule 5605. The Nasdaq letter further provides that, consistent with Nasdaq’s Listing Rule 5605(c)(4), Nasdaq will provide the Partnership a cure period in order to regain compliance as follows: (a) until the earlier of the Partnership’s next annual unitholders’ meeting or October 30, 2026; or (b) if the next annual unitholders’ meeting is held before April 28, 2026, then the Partnership must evidence complian
  evidence_url: https://www.sec.gov/Archives/edgar/data/1172358/000143774925034432/0001437749-25-034432-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.